Why is immunotherapy for glioblastoma "Lag"-ging

Oncotarget. 2019 Feb 8;10(12):1228-1229. doi: 10.18632/oncotarget.26648.

Authors

Dimitrios Mathios¹, Michael Lim¹

Affiliation

¹ Department of Neurosurgery, Oncology and Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD, USA.

No abstract available

Keywords: LAG-3; PD-1; glioblastoma.

Publication types

Editorial